Europe Cervical Cancer Market had a value of USD 9.83 billion in 2024 and is expected to touch USD 15.27 billion by 2033, with a CAGR of 5.01% from 2025 to 2033. The market growth is fueled by technological improvements in early detection products, rising awareness campaigns, and government policies promoting routine screening and HPV vaccination. Growing healthcare spends and enhanced diagnostic facility access are also fueling market growth.